Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma

Simon Haefliger(University of Bern), Daniel Rauch(Washington University in St. Louis), Ruben Bill(University Hospital of Bern), Roland Giger(University of Bern)

Journal of Cancer Research and Clinical Oncology

December 4, 2024

10.1007/s00432-024-06044-2

Cited by 1

Related Papers

<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers

|Science|2023|618

A neutrophil response linked to tumor control in immunotherapy

|Cell|2023|393

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

|The Lancet|2015|392

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

|The Lancet Respiratory Medicine|2017|184

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

|Annals of Oncology|2016|140